176 related articles for article (PubMed ID: 3157206)
1. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Dische S
Radiother Oncol; 1985 Feb; 3(2):97-115. PubMed ID: 3157206
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic cell radiosensitizers: expectations and progress in drug development.
Coleman CN
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
Urtasun RC; Coleman CN; Wasserman TH; Phillips TL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
[TBL] [Abstract][Full Text] [Related]
4. Sensitizers and radiation dose fractionation: results and interpretations.
Hill RP
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
[TBL] [Abstract][Full Text] [Related]
5. A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Overgaard J; Overgaard M; Nielsen OS; Pedersen AK; Timothy AR
Br J Cancer; 1982 Dec; 46(6):904-11. PubMed ID: 7150484
[TBL] [Abstract][Full Text] [Related]
6. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
7. Clinical perspectives for the use of new hypoxic cell sensitizers.
Brown JM
Int J Radiat Oncol Biol Phys; 1982 Sep; 8(9):1491-7. PubMed ID: 6216229
[No Abstract] [Full Text] [Related]
8. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
9. Sensitizers and protectors in radiotherapy.
Brown JM
Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876
[TBL] [Abstract][Full Text] [Related]
10. Testing of new hypoxic cell sensitizers in vivo.
Stone HB; Sinesi MS
Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
[No Abstract] [Full Text] [Related]
11. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
13. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
14. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic cell radiosensitizers--present and future.
Wasserman TH
Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):849-52. PubMed ID: 6457019
[No Abstract] [Full Text] [Related]
16. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
Guichard M; Malaise EP
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
[TBL] [Abstract][Full Text] [Related]
17. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Bleehen NM; Ward R; Workman P
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxic sensitizers in radiotherapy.
Singh DR; Krishnan D
Indian J Cancer; 1981 Mar; 18(1):63-8. PubMed ID: 7262909
[No Abstract] [Full Text] [Related]
20. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Ward R; Workman P; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
